Clinical Trial Update: Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating empagliflozin added to insulin in Japanese patients with type 1 diabetes mellitus has completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (Jardiance) (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2018-04-02